Use of a melanoma inhibiting activity factor (MIA) for...

Details Use of a melanoma inhibiting activity factor (MIA) for... Use of a melanoma inhibiting activity factor (MIA) for...

2005-05-10

2005-05-10

Andres, Janet (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S350000, C424S198100, C424S424000

Reexamination Certificate

active

06890897

ABSTRACT:
A melanoma inhibiting activity factor (MIA), preferably in combination with an osteoinductive protein, is a useful pharmaceutical agent for promoting bone healing and/or cartilage repair.

REFERENCES:
patent: 4919929 (1990-04-01), Beck
patent: 5770366 (1998-06-01), Bogdahn et al.
patent: 6150118 (2000-11-01), Bosserhoff et al.
patent: 6331312 (2001-12-01), Lee et al.
patent: 92 09697 (1992-06-01), None
patent: 95 03328 (1995-02-01), None
patent: 98 30234 (1998-07-01), None
Zhou et al., Genes and Development, 1997, vol. 11, pp. 2191-2203.*
BioRad Catalogue, 1992.*
Bosserhoff, et al., “Structure and Promoter Analysis of the gene encoding . . . MIA”, Journ. of Biological Chemistry, vol. 271, No. 1.
Bosserhoff, et al. “Melanoma-Inhibiting Activity, a Novel Serum . . . Melanoma”, Cancer Research, vol. 57, No. 15.

Affiliated with

Also associated with

Rating

Use of a melanoma inhibiting activity factor (MIA) for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a melanoma inhibiting activity factor (MIA) for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a melanoma inhibiting activity factor (MIA) for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3400798